Home › Funds › Rangeley Capital, LLC › RLYB

Rangeley Capital, LLC position in RLYB

RALLYBIO CORP · Health Care

Rangeley Capital, LLC reported holding 104,850 shares of RLYB (RALLYBIO CORP) in its Q2 2026 13F filing — a position valued at US$1.7M, representing 1.60% of its reported portfolio and ranking #15 among its reported holdings. Rangeley Capital, LLC has disclosed RLYB holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)104.85K sh
Reported value held$1.68M
Portfolio Weight1.60%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rangeley Capital, LLC's RLYB position evolved

Rangeley Capital, LLC first disclosed a stake in RLYB in Q3 2025 at 83,007 shares (US$41K). The position peaked in Q2 2026 at 104,850 shares, worth US$1.7M. Across 4 filings, Rangeley Capital, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 104,850 shares valued at US$1.7M — an increase of 74,720 shares quarter over quarter.. Notable position changes include a 52% trim in Q4 2025 (shares rose 63% over the following quarter), a 248% increase in Q2 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 83.01K $41.42K New
Q4 2025 40.00K $27.44K Reduce
Q1 2026 30.13K $270.27K Reduce
Q2 2026 104.85K $1.68M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLYB and 13F data

RLYB (RALLYBIO CORP) is a Health Care company. 24 other funds we track also report a position in RLYB — the largest reported positions include ADAR1 Capital Management, LLC (US$14.8M), TPG GP A, LLC (US$6.1M), Pivotal bioVenture Partners Investment Advisor LLC (US$4.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLYB

All RLYB fund holders →

FAQ

How long has Rangeley Capital, LLC held RLYB?

Rangeley Capital, LLC has disclosed RLYB holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Rangeley Capital, LLC's current position in RLYB?

As of Q2 2026, Rangeley Capital, LLC holds 104.85K shares of RLYB (RALLYBIO CORP), valued at $1.68M, representing 1.60% of its reported portfolio and ranking #15.

Has Rangeley Capital, LLC been buying or selling RLYB?

In the latest 13F filing (Q2 2026), Rangeley Capital, LLC increased its position in RLYB. The position peaked in Q2 2026 at 104.85K shares.

Which other funds hold RLYB?

Other major institutional holders of RLYB include ADAR1 Capital Management, LLC, TPG GP A, LLC, Pivotal bioVenture Partners Investment Advisor LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.